TEVA PHARMACEUTICAL INDUSTRIES LIMITED Excess Tax Benefit from Share-based Compensation, Financing Activities
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $14.00 million for the 12-month period ending 2010-12-31, per its 20-F filed 2011-02-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2011-02-15
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED excess tax benefit from share-based compensation, financing activities for the quarter ending 2010-12-31 was $3.00M, a 40.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED excess tax benefit from share-based compensation, financing activities for the quarter ending 2010-09-30 was $1.00M, a 85.71% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED excess tax benefit from share-based compensation, financing activities for the quarter ending 2010-06-30 was $3.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED excess tax benefit from share-based compensation, financing activities for the quarter ending 2010-03-31 was $7.00M, a 16.67% increase year-over-year.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2010-12-31 | $3.00M derived: 20-F 12 month − 6-K 9 month · filed 2011-02-15 | $4.00M derived: sum of 2 quarters · filed 2011-02-15 | $7.00M derived: sum of 3 quarters · filed 2011-02-15 | $14.00M 20-F · filed 2011-02-15 |
| 2010-09-30 | $1.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $4.00M derived: sum of 2 quarters · filed 2010-11-02 | $11.00M 6-K · filed 2010-11-02 | $16.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2010-06-30 | $3.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $10.00M 6-K · filed 2010-07-27 | $15.00M derived: sum of 3 quarters · filed 2011-02-15 | $22.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2010-03-31 | $7.00M 6-K · filed 2010-05-04 | $12.00M derived: sum of 2 quarters · filed 2011-02-15 | $19.00M derived: sum of 3 quarters · filed 2011-02-15 | $19.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2009-12-31 | $5.00M derived: 20-F 12 month − 6-K 9 month · filed 2011-02-15 | $12.00M derived: sum of 2 quarters · filed 2011-02-15 | $12.00M derived: sum of 3 quarters · filed 2011-02-15 | $18.00M 20-F · filed 2011-02-15 |
| 2009-09-30 | $7.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $7.00M derived: sum of 2 quarters · filed 2010-11-02 | $13.00M 6-K · filed 2010-11-02 | $23.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2009-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $6.00M 6-K · filed 2010-07-27 | $16.00M derived: sum of 3 quarters · filed 2011-02-15 | $27.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2009-03-31 | $6.00M 6-K · filed 2010-05-04 | $16.00M derived: sum of 2 quarters · filed 2011-02-15 | $27.00M derived: sum of 3 quarters · filed 2011-02-15 | $30.00M derived: sum of 4 quarters · filed 2011-02-15 |
| 2008-12-31 | $10.00M derived: 20-F 12 month − 6-K 9 month · filed 2011-02-15 | $21.00M derived: sum of 2 quarters · filed 2011-02-15 | $24.00M derived: sum of 3 quarters · filed 2011-02-15 | $33.00M 20-F · filed 2011-02-15 |
| 2008-09-30 | $11.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | $14.00M derived: sum of 2 quarters · filed 2009-11-03 | $23.00M 6-K · filed 2009-11-03 | |
| 2008-06-30 | $3.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | $12.00M 6-K · filed 2009-07-29 | ||
| 2008-03-31 | $9.00M 6-K · filed 2009-05-07 | |||
| 2007-12-31 | $36.00M 20-F · filed 2010-02-22 |